2697 — Guangdong True Health Medical Technology Development Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.21bn
- HK$1.66bn
- CNY12.18m
Annual cashflow statement for Guangdong True Health Medical Technology Development, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -92.2 | -90.1 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | -0.651 | -2.15 |
| Unusual Items | ||
| Equity in Net Earnings/Losses | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -16.9 | -13.2 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -97 | -91.9 |
| Capital Expenditures | -7.99 | -3.26 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 1.33 | 0.977 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -6.66 | -2.29 |
| Financing Cash Flow Items | 71.9 | 201 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 65.1 | 193 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -38.6 | 98.5 |